Contacts, documents and full notice history are available with a subscription.
Combined Synopsis/Solicitation NONE Expired 2 notices 3 documents

Unity Real Time License and Quality Control Reagents W81K0225QA081

Solicitation W81K0225QA081 Copied Notice ID 16cb512d511e4e12b89a1fbed44099e0 Copied DEPT OF DEFENSE — W40M MRCO PACIFIC
SAM.gov
Posted
Aug 26, 2025
Deadline
Sep 03, 2025
Set-aside
NONE
NAICS
325412
PSC
6515

Summary

AI-generated · Aug 27, 2025

Provide Unity Real Time Software license and Brand Name Bio-Rad Quality Control reagents to support the Madigan Army Medical Center Department of Pathology’s timely laboratory testing. Must be an authorized Bio-Rad distributor. QC materials will be sequestered to limit changes to at most one lot per contract year, and all QC materials must be identical to those used in the FDA 510K approval. The detailed requirements are in the attached statement of work.

The first notice was a sources-sought market-research request (informational only) to identify capable suppliers; responses were voluntary and not compensation, with no solicitation or bid process yet, and potential solicitations would be posted on the GPE. A combined synopsis/solicitation has now been issued as a formal RFQ for brand-name Bio-Rad QC reagents and Unity Real Time software license, and quotations are being requested as the sole solicitation; refer to the attached Combined Synopsis Solicitation for full details.

The Medical Readiness Contracting Office Pacific, Joint Base Lewis McChord Health Contracting Branch is issuing this sources sought notice for informational purposes only. The notice is a means of conducting market research to identify industry s capabilities. The Madigan Army Medical Center (MAMC) Department of Pathology requires the provision of Unity Real Time Software and Brand Name Bio-Rad Quality Control (QC) materials listed in the attached statement of work, to maintain timely laboratory testing capabilities. Any potential supplier of items required within this contract must be an authorized distributor of Bio-Rad, 2000 Alfred Nobel Drive, Hercules, CA 94547. The manufacturer will sequester the required QC materials to ensure that no more than one lot change occurs per contract year. All QC material provided will be identical to those used in the FDA 510K approval application. See the attached statement of work for additional details. This sources sought notice is not a solicitation for quotations, proposals nor invitation for bids. Any information submitted by respondents to this notice is strictly voluntary and will not be compensated. Telephonic inquiries will not be accepted or acknowledged. The Government will not evaluate the information received nor provide comments or feedback. Your response to the information requested will assist the Government in determining the appropriate acquisition method. Businesses of all sizes are encouraged to respond; however, each respondent must clearly identify their business size in their capabilities and qualifications statement. A determination by the Government not to compete this proposed effort based upon responses to this notice is solely within the discretion of the Government. The Government is not obligated to issue a solicitation nor award a contract under this announcement. If a solicitation is released, it will be synopsized on the Government-Wide Point of Entry (GPE). It is the responsibility of potential offerors to monitor the GPE for additional information pertaining to this requirement. Eligibility The applicable NAICS code for this requirement is 325413 In-Vitro Diagnostic Substance Manufacturing with a small business size standard of 1,250 employees. The product service code is 6550 in vitro diagnostic substances, reagents, test kits and sets. Businesses of all sizes are encouraged to respond. Submission Details Interested parties are requested to submit responses via email. The interested party are encouraged to submit a capability statement that clearly demonstrates their software and quality control products meet all the salient characteristics, timeliness and testing capabilities. Additionally, the Government requests that interested parties provide information for the corresponding reagents required for testing. The email subject line should be Sources Sought Response for W81K0225QA081. Capability Statements may be in either Microsoft Word, Portable Document Format (PDF), and shall be addressed to dylan.j.ford.civ@health.mil and scott.a.barr.civ@health.mil. Proprietary, classified, confidential, or sensitive information should not be included in your response.

From Sources Sought posted on Jul 25, 2025

REQUEST FOR QUOTATION (RFQ) - W81K0225QA081 Brand Name Bio-Rad Quality Control Reagents & Unity Real Time Software License This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 and FAR Part 12 and 13, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotations are being requested and a written solicitation will not be issued. For further details see attached Combined Synopsis Soliciation.

From Combined Synopsis/Solicitation posted on Aug 26, 2025

Notice history

2
  1. Sources Sought Posted Jul 25, 2025 View
  2. Combined Synopsis/Solicitation LATEST Posted Aug 26, 2025
    • Description: Description was updated
    • Notice Type: Sources SoughtCombined Synopsis/Solicitation
    • Response Deadline: Jul 30, 2025Sep 03, 2025

Details

Solicitation number W81K0225QA081
Notice ID 16cb512d511e4e12b89a1fbed44099e0
Notice type Combined Synopsis/Solicitation
Product / Service (PSC) 6515
NAICS 325412
Set-aside No Set aside used
Place of performance Washington
Archive date Sep 18, 2025

Award Information

Not yet awarded

Contacts

primary
Dylan Ford

Email

secondary
Scott Barr

Email

Agency

DEPT OF DEFENSE
DEPT OF THE ARMY
US ARMY MEDICAL COMMAND
W40M MRCO PACIFIC

Place of Performance

Washington 98431
USA

Dates

Posted Aug 26, 2025 11 months ago
Last Updated Aug 06, 2026 2 days ago
Due Sep 03, 2025 11 months ago